Background
Methods
Study Design, Population and Recruitment
Data Collection
Laboratory Methods
Data Analysis
Results
Enrollment
Sociodemographic Characteristics
Characteristics | N | Percent | |
---|---|---|---|
Age (Years) (Mean ± s.d.)
| 28.5 ± 7.4 | ||
Education
| |||
Primary or less
| 175 | 9.8 | |
High school or less
| 1392 | 77.5 | |
Some higher education
| 228 | 12.7 | |
City
| |||
Lima/Callao
| 1400 | 77.9 | |
Trujillo
| 186 | 10.4 | |
Chiclayo
| 107 | 6.0 | |
Ica
| 103 | 5.7 | |
Employment
| |||
Steady employment
| 977 | 54.1 | |
Occasional employment
| 403 | 22.5 | |
Unemployed
| 82 | 4.6 | |
Other
| 335 | 18.7 | |
Relationship w/pregnant woman
| |||
Girlfriend/Fiancée
| 124 | 7.0 | |
Live-in partner
| 1228 | 68.9 | |
Wife
| 431 | 24.1 | |
Time with pregnant woman (years, Median IQR)
| 2 (1–5) | ||
Lifetime sexual partners (Median IQR)
| 4 (2–8) | ||
Sexually active years (Mean ± s.d.)
| 12.2 ± 7.9 | ||
Age at sexual debut (years) (Mean ± s.d.)
| 16.3 ± 3.3 | ||
Previous STI
| 207 | 11.5 | |
Genital ulcer, last 12 months
| 204 | 11.4 | |
(Non-injection) Drug use, last 12 months
| 125 | 7.0 | |
Sexual contact with FSW, lifetime
| 668 | 37.1 | |
Sexual contact with FSW, previous 12 months
| 158 | 8.9 | |
Unprotected sexual contact with FSW, previous 12 months
| 22 | 1.2 | |
Sexual contact with male, lifetime
| 197 | 11.0 | |
Sexual contact with male, previous 12 months
| 31 | 1.7 | |
Unprotected sexual contact with male, previous 12 months
| 16 | 0.9 |
Prevalence of STIs
Risk Factor | HSV-2 n/N (%) | Syphilis n/N (%) | HIV n/N (%) |
---|---|---|---|
Overall | 287/1796 (15.9%) | 28/1796 (1.6%) | 15/1796 (0.8%) |
Age | |||
16 – 22 | 37/383 (9.7%) | 5/383 (1.3%) | 2/383 (0.5%) |
23 – 26 | 51/462 (11.0%) | 3/462 (0.6%) | 6/462 (1.3%) |
27 – 32 | 85/467 (17.5%) | 9/487 (1.8%) | 4/487 (0.8%) |
33+ | 114/463 (24.6%)‡
| 11/463 (2.4%) | 3/463 (0.6%) |
# Lifetime sexual partners | |||
1 – 2 | 42/362 (11.6%) | 3/362 (0.8%) | 2/362 (0.6%) |
3 – 4 | 66/435 (15.2%) | 2/435 (0.5%) | 3/435 (0.7%) |
5 – 9 | 57/429 (13.3%) | 9/429 (2.1%) | 3/429 (0.7%) |
10+ | 108/432 (25.0%)‡
| 11/432 (2.5%)* | 6/432 (1.4%) |
# Sexually active years | |||
0 – 6 | 39/450 (8.7%) | 4/450 (0.9%) | 3/450 (0.7%) |
7 – 11 | 59/522 (11.3%) | 6/522 (1.1%) | 4/522 (0.8%) |
12 – 17 | 80/416 (19.2%) | 7/416 (1.7%) | 5/416 (1.2%) |
18+ | 109/407 (26.8%)‡
| 11/407 (2.7%)* | 3/407 (0.7%) |
History of STI | |||
No | 226/1589 (14.2%) | 20/1589 (1.3%) | 11/1589 (0.7%) |
Yes | 61/204 (29.9%)‡ | 8/207 (3.9%)†
| 4/207 (1.9%) |
History of sex with men, lifetime | |||
No | 143/1599 (14.6%) | 23/1599 (1.4%) | 12/1599 (0.8%) |
Yes | 54/197 (27.4%)‡
| 5/197 (2.5%) | 3/197 (1.5%) |
History of sex with FSW, lifetime | |||
No | 150/1128 (13.3%) | 15/1128 (1.3%) | 10/1128 (0.9%) |
Yes | 137/688 (20.5%)‡
| 13/668 (1.9%) | 5/668 (0.7%) |
Non-injection illegal drug use, last year | |||
No | 256/1671 (15.3%) | 26/1671 (1.6%) | 13/1671 (0.8%) |
Yes | 31/125 (24.8%)†
| 2/125 (1.6%) | 2/125 (1.6%) |
Genital ulcer, last year | |||
No | 226/1592 (14.2%) | 19/1592 (1.2%) | 13/1592 (0.8%) |
Yes | 61/204 (29.9%)‡ | 9/204 (4.4%)‡
| 2/204 (1.0%) |
Sexual Behavior
Risk Factors Associated with STIs
Risk Factor | HSV-2 | Syphilis | HIV Unadjusted OR (95% CI) | ||
---|---|---|---|---|---|
Unadjusted OR (95% CI) | Adjusted OR (p-value, 95% CI) | Unadjusted OR (95% CI) | Adjusted OR (95% CI) | ||
Age (per additional year) | 1.07‡ (1.05 – 1.08) | - | 1.06† (1.02 – 1.10) | 1.04 (1.00 – 1.09) | 1.00 0.93 – 1.07 |
# Lifetime sexual partners (per additional partner) | 1.01† (1.00 – 1.01) | - | 1.01† (1.00 – 1.01) | 1.00 (1.00 – 1.01) | 1.00 (0.97 – 1.02) |
# Sexually active years (per additional year) | 1.07‡ (1.05 – 1.08) | 1.07 (<0.001, 1.05 – 1.09) | 1.06† (1.02 – 1.10) | - | 1.00 (0.94 – 1.07) |
History of sex with men, lifetime | 2.22‡ (1.57 – 3.11) | - | 1.78 (0.67 – 4.75) | - | 2.06 (0.57 – 7.31) |
History of sex with FSW, lifetime | 1.68‡ (1.30 – 2.17) | - | 1.47 (0.70 – 3.11) | 0.85 (0.29 – 2.48) | |
Non-injection illegal drug use, last year | 1.82† (1.19 – 2.79) | 2.23 (0.008, 1.43 – 3.49) | 1.03 (0.24 – 4.39) | - | 2.08 (0.46 – 9.29) |
HSV-2 infection | - | - | 3.50† (1.62 – 7.55) | 2.09 (0.89 – 4.91) | 8.12‡ (2.86 – 22.96) |
Syphilis infection | 3.50† (1.62 – 7.55) | - | - | - | N/A° |
HIV infection | 8.12‡ (2.86 – 22.96) | 8.58 (<0.001, 2.95 – 24.99) | N/A° | N/A° | - |